About me
YOU Hoi-sze, Joyce 姚凱詩
PharmD, BCPS
Director and Professor, School of Pharmacy
Assistant Dean (Student Engagement), Faculty of Medicine
The Chinese University of Hong Kong
Tel: (852) 3943 6862
Fax:(852) 2603 5295
Email: pharmacy@cuhk.edu.hk
Personal Details
Prof. Joyce You joined the School of Pharmacy in 1999. She earned her Doctor of Pharmacy (PharmD) degree from the University of Illinois at Chicago (US) and completed her Pharmacy Practice Residency at the University of Michigan (US). Prof. You is a certified Specialist by the Board of Pharmacy Specialties (US) in Pharmacotherapy.
Prof. You has initiated cost-effectiveness studies in collaboration with researchers from the disciplines of Cardiology, Clinical Pharmacology, Gastroenterology & Hepatology, Haematology, Infectious Diseases, Microbiology, Obstetrics & Gynaecology, Oncology, Orthopedics & Traumatology, Public Health, Psychology, and Psychiatry.
Prof. You had led a randomised clinical trial comparing outcomes of pharmacist-managed versus physician-managed anticoagulation clinic. As a result of this project, the first clinical pharmacist-managed anticoagulation clinic in Hong Kong was established at the Prince of Wales Hospital (PWH) in 2002 and now sustained by the staff of Pharmacy Department at PWH.
Research
Research Interests
The focus of Dr. You’s research is the methodology development of pharmacoeconomics and health outcomes research, especially simulation designs using decision tree and Markov models. She works closely with Infectious Diseases and Microbiology physicians on outcome studies of infections caused by multi-drug resistant bacteria and emerging viruses. Much of her work also involves the study of anticoagulation therapy for Chinese patients, including the optimal control of anticoagulation therapy, the cost-effectiveness of the various models of care for patients receiving warfarin, and the role and cost-effectiveness of pharmacogenetic testing for Chinese patients receiving anticoagulation therapy.
Teaching
Teaching
- Bachelor of Pharmacy Programme
- PHAR1440 Clinical Microbiology and Infection Control
- PHAR3413 Pharmacology & Therapeutics II
- PHAR3415 Pharmacology & Therapeutics IV
- PHAR4303 Clinical Pharmacy Clerkship: Infectious Diseases
- PHAR4911 Research Project I
- PHAR4912 Research Project II
- MPhil & PhD in Pharmacy
- PHAR5130 Overview of Drug Development
- Master of Clinical Pharmacy Programme
- PHAR 5882 Pharmacotherapy: Infectious Diseases
- PHAR5924 Graduation Project II
Publications
Recent Publications
- Wang Y, Rui M, You JHS. Intradermal hepatitis B vaccination with imiquimod pretreatment in dialysis patients: a cost-effectiveness analysis. Cost Effectiveness and Resource Allocation. 2025;24(1):4. doi: 10.1186/s12962-025-00682-0.
- You JHS, Luk SWC, Chow DYW, Mak ADP, Mak WWS. Internet-based mental health intervention for depressive symptoms in young adults: A cost-effectiveness analysis. JMIR Human Factors. 2025;12:e68167. doi: 10.2196/68167.
- Wang Y, Rui M, Wei Q, Leung TF, Leung TY, You JHS. Cost-effectiveness of Maternal Vaccination against Respiratory Syncytial Virus in Hong Kong: A Decision-analytical Analysis. Expert Review of Vaccines. 2025 Dec;24(1):1015-1023. doi: 10.1080/14760584.2025.2589208.
- Wei Q, Wang Y, Rui M, You JHS. Health economic evaluations of fecal microbiota transplantation for non-Clostridioides difficile related diseases: A Systematic Review. Health Economics Review. 2025;15(1):103. doi: 10.1186/s13561-025-00698-5.
- Wei Q, Rui M, Wang Y, Ng SC, You JHS. Cost-effectiveness analysis of fecal microbiota transplantation for patients with irritable bowel syndrome. Digestion. 2025 Nov 11:1-21. doi: 10.1159/000549485. Epub ahead of print.
- Wang Y, Rui M, Wei Q, Leung TF, You JHS. Cost-effectiveness Analysis of Nirsevimab for Respiratory Syncytial Virus Disease Prevention in Newborns of Hong Kong. Influenza and Other Respiratory Viruses. 2025 Oct;19(10):e70153. doi: 10.1111/irv.70153.
- Rui M, Wang Y, Wei Q, You JHS. Homologous recombination repair (HRR) deficiency-guided use of talazoparib plus enzalutamide in patients with metastatic castration-resistant prostate cancer: A cost-effectiveness analysis. Therapeutic Advances in Medical Oncology. 2025 Jul 13;17:17588359251356109. doi: 10.1177/17588359251356109.
- Rui M, Wang Y, You JHS. Novel non-invasive tests for colorectal cancer screening – A cost-effectiveness analysis. Cancer Epidemiology, Biomarkers & Prevention. 2025 Feb 21. doi: 10.1158/1055-9965.EPI-24-1549.
- Rui M, Wang Y, You JHS. Health Economic Evaluations of Circulating Tumor DNA Testing for Cancer Screening: Systematic Review. Cancer Medicine. 2025 Feb;14(3):e70641. doi: 10.1002/cam4.70641.
- Xie M, You JHS. Deprescribing of proton pump inhibitors in older patients: A cost-effectiveness analysis. PLoS One. 2024 Oct 7;19(10):e0311658. doi: 10.1371/journal.pone.0311658.
Supplementary Information
Awards
Teacher of the Year Award 2005/06, School of Pharmacy, Faculty of Medicine, CUHK
Teacher of the Year Award 2010/11, School of Pharmacy, Faculty of Medicine, CUHK